DE BERARDINIS, Ettore
 Distribuzione geografica
Continente #
NA - Nord America 5.783
EU - Europa 3.904
AS - Asia 1.573
SA - Sud America 127
AF - Africa 43
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 6
Totale 11.456
Nazione #
US - Stati Uniti d'America 5.727
IT - Italia 2.588
SG - Singapore 830
IN - India 344
CN - Cina 259
SE - Svezia 206
DE - Germania 180
FI - Finlandia 173
RU - Federazione Russa 162
UA - Ucraina 128
BR - Brasile 98
FR - Francia 84
GB - Regno Unito 77
BG - Bulgaria 59
CA - Canada 49
ID - Indonesia 49
NL - Olanda 48
BE - Belgio 37
IE - Irlanda 35
PL - Polonia 31
RO - Romania 26
TG - Togo 26
AR - Argentina 20
CH - Svizzera 18
AU - Australia 17
AT - Austria 16
PH - Filippine 13
HK - Hong Kong 12
ES - Italia 7
IL - Israele 7
IR - Iran 7
JP - Giappone 7
KR - Corea 7
IQ - Iraq 6
ZA - Sudafrica 6
EU - Europa 5
GR - Grecia 5
MK - Macedonia 5
CO - Colombia 4
EG - Egitto 4
RS - Serbia 4
TR - Turchia 4
VN - Vietnam 4
AZ - Azerbaigian 3
BZ - Belize 3
DK - Danimarca 3
JO - Giordania 3
KE - Kenya 3
LU - Lussemburgo 3
MX - Messico 3
NZ - Nuova Zelanda 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BD - Bangladesh 2
CL - Cile 2
HU - Ungheria 2
LT - Lituania 2
LV - Lettonia 2
SC - Seychelles 2
BH - Bahrain 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
GE - Georgia 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.456
Città #
Fairfield 757
Chandler 483
Singapore 381
Rome 369
Woodbridge 366
Ashburn 357
Seattle 324
Houston 292
Wilmington 275
Cambridge 244
Princeton 204
Ann Arbor 196
Plano 132
Santa Clara 129
Milan 128
Beijing 118
San Paolo di Civitate 107
Los Angeles 96
Boston 95
Cosenza 94
Lawrence 91
Millbury 76
San Diego 71
Dearborn 65
Sofia 59
Helsinki 55
Grafing 54
Andover 51
Jacksonville 49
Moscow 49
Naples 48
Jakarta 46
Brussels 37
Des Moines 32
Dublin 32
Norwalk 31
Toronto 31
Bologna 28
Lomé 26
Falkenstein 25
Catania 23
New York 23
Warsaw 23
Boardman 20
Falls Church 18
Kunming 18
Munich 18
Federal 17
Palermo 17
Bari 16
Napoli 16
Auburn Hills 15
Dallas 15
Verona 15
Florence 14
Guangzhou 14
Nanjing 14
Ottawa 14
Yubileyny 14
Hefei 13
Torino 13
Council Bluffs 12
Melbourne 12
Chicago 11
Jinan 11
Bühl 10
Frankfurt am Main 10
Fremont 10
Padova 10
Phoenix 10
Turin 10
Genova 9
São Paulo 9
Amsterdam 8
Bern 8
Buffalo 8
Cagliari 8
L’Aquila 8
San Mateo 8
Brescia 7
Edinburgh 7
Genoa 7
London 7
Mannheim 7
Modena 7
Nuremberg 7
Cantù 6
Columbus 6
Guardiagrele 6
Hong Kong 6
Latina 6
Messina 6
Nanchang 6
Pescara 6
Pune 6
Quezon City 6
San Michele al Tagliamento 6
Southend 6
Stockholm 6
Torre Del Greco 6
Totale 6.758
Nome #
RUOLO DELLA CISTOGRAFIA - TC CON CISTOSCOPIA VIRTUALE MEDIANTE APPARECCHIATURA MULTISTRATO NELLA IDENTIFICAZIONE DELLE NEOPLASIE VESCICALI 904
Raro caso di tumore adenomatoide multiplo ad origine dalla tunica vaginale del testicolo e dell’epididimo. 686
SIGNIFICATO DELLE LESIONI IPERPLASTICO-PROLIFERATIVE DELL'UROTELIO IN PAZIENTI SOTTOPOSTI A CHEMIOTERAPIA ENDOVESCICALE DOPO TUR O TVR PER CARCINOMA SUPERFICIALE DELLA VESCICA 524
Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®) 142
APPROCCIO PENOSCROTALE VERSUS TECNICA MINI-INVASIVA INFRAPUBICA PER IL POSIZIONAMENTO DI PROTESI PENIENA TRICOMPONENTE: UNO STUDIO “MATCHED PAIRED” IN UN SINGOLO CENTRO 132
A chemosensitivity test to individualize intravesical treatment for non-muscle-invasive bladder cancer 119
Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center 113
null 108
From Myo-inositol to D-chiro-inositol molecular pathways 108
Circulating tumor cells identify patients with super-high-risk non-muscle-invasive bladder cancer: updated outcome analysis of a prospective single-center trial 106
An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer 101
null 96
A NEW MOLECULAR CHEMOSENSITIVITY TEST TO IMPROVE AND PREDICT EFFICACY OF INTRAVESICAL ADJUVANTTHERAPY IN NMIBC (NON MUSCLE INVASIVE BLADDER CANCER) 94
Knotless "three-U-stitches" technique for urethrovesical anastomosis during laparoscopic radical prostatectomy 94
CIRCULATING TUMOR CELLS AND THEIR PROGNOSTICSIGNIFICANCE IN NON MUSCLE INVASIVE BLADDER CANCER:A CELLSEARCH ANALYSIS. 93
Penoscrotal versus minimally invasive infrapubic approach for inflatable penile prosthesis placement: a single-center matched-pair analysis 92
Exploring the utility of a NGS multigene panel to predict BCG response in patients with non-muscle invasive bladder cancer 88
Androgen-deprivation therapy and SARS-Cov-2 infection: the potential double-face role of testosterone 88
Primary Metastatic Neuroendocrine Small Cell Bladder Cancer: A Case Report and Literature Review 87
A systematic review and meta-analysis of clinical trials implementing aromatase inhibitors to treat male infertility 86
Distal corporal anchoring stitch: a technique to address distal corporal crossovers and impending lateral extrusions of a penile prosthesis 83
Risk decrease of intra-operative bleeding during TURP with the uptake of Finasteride: Evaluation of VEGF and CD34. 80
Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer 80
The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC) 80
Geometrical modified Nesbit corporoplasty to correct different types of penile curvature: description of the surgical procedure based on geometrical principles and long-term results 80
Biomarkers in prostate cancer diagnosis: from current knowledge to the role of metabolomics and exosomes 80
Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs 78
Cribriform pattern does not have a significant impact in Gleason Score ≥7/ISUP Grade ≥2 prostate cancers submitted to radical prostatectomy 78
Penoscrotal versus minimally invasive infrapubic approach for inflatable penile prosthesis placement: A single-center matched paired analysis 77
Impianto di protesi peniena: dal recupero della funzione erettile alla riabilitazione sessuale 75
Incidental prostatic stromal tumor of uncertain malignant potential (STUMP): histopathological and immunohistochemical findings. 75
PRIMARY METASTATIC RENAL CARCINOID IN HORSESHOE KIDNEY 74
Impact of uni- or multifocal perineural invasion in prostate cancer at radical prostatectomy 74
Modeling the contribution of male testosterone levels to the duration of positive COVID testing among hospitalized male COVID-19 patients 73
Prostate Cancer Gene 3 and Multiparametric Magnetic Resonance Can Reduce Unnecessary Biopsies: Decision Curve Analysis to Evaluate Predictive Models 71
Efficacy and safety of finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia. a critical review of the literature 71
Use of inflatable penile prostheses AMS CX with momentary squeeze in a patient with Peyronie's disease after removal of two previously implanted penile prostheses 71
The accuracy of vesical imaging-reporting and data system (VI-RADS): an updated comprehensive multi-institutional, multi-readers systematic review and meta-analysis from diagnostic evidence into future clinical recommendations 71
Safety and feasibility of outpatient surgery in benign prostatic hyperplasia: a systematic review and meta-analysis 70
Compared efficacy of adjuvant intravesical bcg-tice vs. bcg-rivm for high-risk non-muscle invasive bladder cancer (nmibc). a propensity score matched analysis 69
Recurrent transitional cell carcinoma of the bladder: A mixed nested variant case report and literature review. 68
High risk non-muscle invasive bladder cancer: prognostic factor of circulating tumour cells. 68
Contemporary trends of systemic neoadjuvant and adjuvant intravesical chemotherapy in patients with upper tract urothelial carcinomas undergoing minimally invasive or open radical nephroureterectomy: analysis of US claims on perioperative outcomes and health care costs 68
Sling uretrale con tecnica transutturatoria (TOT) nell’incontinenza urinaria da sforzo (IUS): valutazione dei risultati con follow-up di 5 anni 67
Postoperative vacuum therapy following AMS™ LGX 700® inflatable penile prosthesis placement: penile dimension outcomes and overall satisfaction 67
T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy 67
Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors 67
Body mass index and age correlate with antioxidant supplementation effects on sperm quality: Post hoc analyses from a double-blind placebo-controlled trial 66
Comparison of the clinical usefulness of different urinary tests for the initial detection of bladder cancer: a systematic review 65
Reduced intraoperative bleeding during transurethral resection of the prostate: Evaluation of finasteride, vascular endothelial growth factor, and CD34 64
Penile fracture: Penoscrotal approach with degloving of penis after Magnetic Resonance Imaging (MRI) 63
Association of daily step count and serum testosterone among men in the United States 62
Predictors of residual T1 high grade on re-transurethral resection in a large multi-institutional cohort of patients with primary T1 high-grade/grade 3 bladder cancer 61
Validation of neutrophil-to-lymphocyte ratio in a multi-institutional cohort of patients with T1G3 non–muscle-invasive bladder cancer 61
SelectMDx and multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy: a prospective assessment in a multi-institutional study 61
Influence of operative time and blood loss on surgical margins and functional outcomes for laparoscopic versus robotic-assisted radical prostatectomy: a prospective analysis 60
Prognostic role of flow cytometry in superficial bladder cancer 59
Effect of metabolic and antioxidant supplementation on sperm parameters in oligo-astheno-teratozoospermia, with and without varicocele: a double-blind placebo-controlled study 59
Hyperhomocysteinemia as an early predictor of erectile dysfunction: International index of erectile function (IIEF) and penile doppler ultrasound correlation with plasma levels of homocysteine 59
Non-ischemic priapism following recurrent idiopathic ischemic priapism treated successfully with selective arterial embolization and postoperative vacuum therapy before delayed inflatable penile prosthesis placement. a single case report 59
PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study. 59
Surgical blood loss during holmium laser enucleation of the prostate (holep) is not affected by short-term pretreatment with dutasteride. a double-blind placebo-controlled trial on prostate vascularity 57
How Can the COVID-19 Pandemic Lead to Positive Changes in Urology Residency? 57
Prognostic factor of circulating tumor cells in high risk non-muscle invasive bladder cancer 57
Gemcitabina endovescicale nelle NMIBC: valutazione degli effetti collaterali ed analisi farmacodinamica 56
ASPETTI INCONSUETI DELLA PATOLOGIA OSTRUTTIVA CERVICO-URETRALE:LE CISTI PROSTATICHE,DESCRIZIONE DI UN CASO 56
An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer 56
Association between male infertility and male-specific malignancies: systematic review and meta-analysis of population-based retrospective cohort studies 56
Translation and validation of the Italian version of the Wisconsin Stone Quality of Life Questionnaire (I-WISQOL) for assessing quality of life in patients with urolithiasis 55
Seeing is believing: state of the art Imaging of bladder cancer 55
Intravesical administration of gemcitabine in superficial bladder cancer: a phase I study with pharmacodynamic evaluation 55
Superselective embolization of bladder arteries in the treatment of intractable bladder haemorrhage 55
Prognostic significance of survivin-expressing tumor cells in T1G3 bladder cancer 55
High-grade T1 on re-transurethral resection after initial high-grade T1 confers worse oncological outcomes. Results of a multi-institutional study 55
SARS-CoV-2 infection and high-risk non-muscle-invasive bladder cancer: are there any common features? 55
A Biofeedback guided program or pelvic floor muscle electric stimulation can improve early recovery of urinary continence after radical prostatectomy: a meta-analysis and systematic review 55
The association between mortality and male infertility: systematic review and meta-analysis 55
Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy 54
Systematic review and meta-analysis of vesical imaging-reporting and data system (Vi-rads) inter-observer reliability: an added value for muscle invasive bladder cancer detection 54
Vesical imaging-reporting and data system (VI-RADS) for assessment of response to systemic therapy for bladder cancer: preliminary report 54
Radical Cystectomy for Stage T1g3 Transitional Cell Carcinoma of the Bladder: Long-term Follow-up 53
Neoplasie primitive della vescica T1G3: recidive e progressioni. Dieci anni di follow-up 53
ENDOVESICAL THERAPY IN HIGH RISK NON MUSCLE INVASIVE BLADDER CANCER: A NEW CHEMOSENSITIVITY TEST 53
null 53
Predictive value of MCM5 (ADXBLADDER) analysis in urine of men evaluated for the initial diagnosis of bladder cancer: a comparative prospective study 53
The clinical efficacy of nitrofurantoin for treating uncomplicated urinary tract infection in adults: a systematic review of randomized control trials 53
Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer: a CellSearch analysis. 53
The association of impaired semen quality and pregnancy rates in assisted reproduction technology cycles. systematic review and meta-analysis 53
EVALUATION AND PROGNOSTIC FACTOR OF CIRCULATING TUMOR CELL IN NMIBC (NON-MUSCLE INVASIVE BLADDER CANCER) 52
Modified glasgow prognostic score is associated with risk of recurrence in bladder cancer patients after radical Cystectomy. A multicenter experience 52
A systematic review and meta-analysis of randomized controlled trials with novel hormonal therapies for non-metastatic castration-resistant prostate cancer: an update from mature overall survival data 52
NEW PROTOCOL OF CT CYSTOGRAPHY (CTC) WITH DUAL SOURCE TECHNIQUE IN DETECTION OF BLADDER LESION 52
HIGH-RISK NMIBC (NON-MUSCLE INVASIVE BLADDERCANCER): PROGNOSTIC VALUE OF CIRCULATINGTUMOR CELLS 52
null 50
null 50
Intravesical administration of gemcitabine in superficial bladder cancer: A phase I study with pharmacodynamic evaluation. A phase II study with chemoresection of the marker lesion 50
Evaluation of the prognostic factors in bladder cancer 49
Carcinoma in situ della vescica: nostra esperienza 49
SURVIVIN EXPRESSING CIRCULATING TUMOR CELLS IN NONMUSCHE INVASIVE BLADDER CANCER: A CELLECTION™ DYNABEADS ANALYSIS 49
MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING OF THE PROSTATE AND PCA3 URINARY TEST: IS TIME TO RE-EVALUATE PROSTATE BIOPSY? 49
Totale 8.783
Categoria #
all - tutte 37.878
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.878


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020493 0 0 0 0 0 0 0 0 158 120 128 87
2020/20211.204 95 89 85 122 45 40 37 105 93 181 248 64
2021/20222.075 52 103 170 98 276 99 77 192 162 144 360 342
2022/20231.933 395 319 89 203 225 177 33 139 164 37 107 45
2023/20241.279 83 154 57 118 118 202 41 97 17 153 93 146
2024/20251.999 110 132 147 183 199 190 230 240 568 0 0 0
Totale 11.943